News
LOBEF
0.032
NaN%
--
Weekly Report: what happened at LOBEF last week (1109-1113)?
Weekly Report · 2d ago
Weekly Report: what happened at LOBEF last week (1102-1106)?
Weekly Report · 11/09 10:19
Weekly Report: what happened at LOBEF last week (1026-1030)?
Weekly Report · 11/02 10:19
Weekly Report: what happened at LOBEF last week (1019-1023)?
Weekly Report · 10/26 10:18
Weekly Report: what happened at LOBEF last week (1012-1016)?
Weekly Report · 10/19 10:18
Lobe Sciences Adds Veteran Life Sciences Banker Annette Grimaldi to Board
TipRanks · 10/14 12:42
Weekly Report: what happened at LOBEF last week (1005-1009)?
Weekly Report · 10/12 10:24
Lobe Sciences Plans Capital Markets Push as Key Drug Programs Advance
TipRanks · 10/08 13:23
Weekly Report: what happened at LOBEF last week (0928-1002)?
Weekly Report · 10/05 10:23
Weekly Report: what happened at LOBEF last week (0921-0925)?
Weekly Report · 09/28 10:18
Weekly Report: what happened at LOBEF last week (0914-0918)?
Weekly Report · 09/21 10:19
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
Barchart · 09/14 22:00
Weekly Report: what happened at LOBEF last week (0907-0911)?
Weekly Report · 09/14 10:24
Weekly Report: what happened at LOBEF last week (0831-0904)?
Weekly Report · 09/07 10:17
Lobe Sciences Raises $2.16 Million in Upsized Private Placement to Advance Sickle Cell Drug
TipRanks · 09/01 01:02
Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
Barchart · 08/31 18:00
Weekly Report: what happened at LOBEF last week (0824-0828)?
Weekly Report · 08/31 10:25
Lobe Sciences Upsizes Private Placement to Fund Sickle Cell and Neurology Pipeline
TipRanks · 08/29 02:32
Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Barchart · 08/28 18:00
Lobe Sciences Names New CFO to Support Growth and Clinical Pipeline
TipRanks · 08/28 13:05
More
Webull provides a variety of real-time LOBEF stock news. You can receive the latest news about Lobe Sciences through multiple platforms. This information may help you make smarter investment decisions.
About LOBEF
Lobe Sciences, Ltd. is a biopharmaceutical company focused on using lipid technology to develop treatments for orphan and rare diseases. The Company, through its wholly owned subsidiaries, Alera Pharma, Inc. and Altemia, Inc., is advancing the development of a patented drug candidate aimed at treating neurological disorders, with an initial focus on chronic cluster headache (Alera). The Company commercializes Altemia MF, a medical food designed to manage deficiencies commonly found in sickle cell disease. Additionally, through Cynaptec Pharmaceuticals, Inc. (Cynaptec), the Company retains an interest in developing Conjugated Psilocin in neurology and psychiatric indications. Conjugated Psilocin is a patented, oral, stable analog of psilocin, the active metabolite of the prodrug psilocybin, designed to enhance bioavailability and therapeutic efficacy, which has been identified as having therapeutic potential in a variety of neurological conditions.